PORTLAND, Oregon, October 6, 2016 /PRNewswire/ --
According to a new report published by Allied Market Research, titled, "Omega-3 Market, by Type, Source, and Application: Global Opportunity Analysis and Industry Forecast, 2014 - 2022," the omega-3 market is expected to reach $6,955 million by 2022, with a CAGR of 14.9% from 2016 to 2022. Docosahexaenoic acid segment (DHA) dominated with three-fourths market share, in terms of revenue, in 2015. Dietary supplement application accounted for three-fifths of the global omega-3 market share, in terms of volume, in 2015 and is anticipated to grow at a CAGR of 14.1%.
Summary of the Omega-3 Market Report can be accessed on the website at https://www.alliedmarketresearch.com/omega-3-market
Omega-3 market is driven by factors such as rise in awareness among consumer about healthy & balanced diet and its health benefits. Moreover, omega-3 supplements such as eicosapentaenoic acid (EPA) and DHA reduces the risk of prostrate, colon, and breast cancer. An adequate amount of EPA decreases risk of depression and related health problems. The regulatory barrier limiting the consumption of omega-3 over certain range may restrain the market growth in the near future. Omega-3 obtained from plant origin, a good source of alpha-linolenic acid (ALA) for vegetarians, provides an opportunity for omega-3 market growth.
The world ALA omega-3 market accounted for over $234 million in 2015. North America dominated the world ALA omega-3 market, in terms of revenue, generating $96 million in 2015. According to Eswara Prasad, Team Lead-Chemicals & Materials at Allied Market Research, "The global ALA market has great potential as compared to DHA and EPA as consumers constantly look for alternatives of fish oil".
Omega-3 has a wide range of applications such as dietary supplement, pharmaceutical, infant formula, food & beverage, pet food, and fish feed. Dietary supplement is the major application and accounted for three-fifths of the global omega-3 market volume in 2015. Pharmaceutical is expected to grow (in terms of revenue) at CAGR of 18% from 2016 to 2022. The consumption of omega-3 (in terms of volume) in pharmaceutical and infant formula is estimated to increase at a higher CAGR of 18.8% and 16.3%, respectively, during the forecast period.
Fish and krill oils are two major marine sources for omega-3 fatty acid. Fish oil is applicable in aquaculture and nutraceuticals. Algal oil is one of the important sources of omega-3 fatty acid ingredients. Algal oil is the major alternative for production of omega-3; however, its relatively high price restricts its anticipated market penetration into the food and dietary supplement.
The omega-3 market for infant formula witnesses' high growth rate, in the packaged food category, due to developments in Asia (particularly China), East Europe markets, and in some parts of Middle East and Latin America. Increase in the global omega-3 production and rise in its demand are the major reasons for the higher growth rate in countries such as Mexico, The Netherlands, Poland, India, and Brazil.
Key findings of the study:
- North America was the dominant region in 2015 both in terms of value & volume and is expected to continue this trend throughout the forecast period.
- Revenue generated by nuts & seeds is estimated to grow at a CAGR of 25.8%.
- Dietary supplement accounted for three-fifths of the global omega-3 demand in 2015.
- Fish & krill oil sources dominated, in terms of revenue, in 2015 and is projected to grow at a CAGR of 14.2%.
- DHA segment is expected to remain dominant throughout the period under consideration.
- U.S. contributed to one-third of the market revenue in 2015.
North America and Europe together contributed more than 60% of the world omega-3 market revenue in 2015. North America dominated the world omega-3 market in pharmaceutical application, in terms of volume; whereas Asia-Pacific is the fastest growing region with a CAGR of 16%, owing to the consumer awareness in the developing countries. China and India together account for three-fifths share (in terms of revenue) of the total Asia-Pacific omega-3 market.
The companies in this market adopt expansion and acquisition as their key strategies to develop distinguished products and reduce competition by capturing additional market share. The prominent players profiled in this report include Cargill, Incorporated, FMC Corporation, Croda International Plc, Royal DSM, OLVEA Fish Oils, Omega Protein Corporation, GC Rieber Oils, Luhua Biomarine (Shandong) Co., Ltd., Pharma Marine AS, and Polaris.
Summary of Similar Reports can be viewed at: https://www.alliedmarketresearch.com/food-&-beverages/nutraceutical-wellness-food-market-report
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions". AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
Toll Free: +1 (800) 792-5285 (U.S. & Canada)
Fax: +1 (855) 550-5975
SOURCE Allied Market Research